Ensign Peak Advisors
ORGO icon

Ensign Peak Advisors’s Organogenesis Holdings ORGO Stock Holding History

Ensign Peak Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,890
Closed -$64K – 2088
2022
Q3 		$64K Hold
19,890
– – ﹤0.01% 2170
2022
Q2 		$97K Hold
19,890
– – ﹤0.01% 1966
2022
Q1 		$152K Hold
19,890
– – ﹤0.01% 1949
2021
Q4 		$184K Sell
19,890
-27,510
-58% -$292K ﹤0.01% 1941
2021
Q3 		$675K Buy
47,400
+5,700
+14% +$88.5K ﹤0.01% 1557
2021
Q2 		$693K Buy
+41,700
New +$777K ﹤0.01% 1535

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ensign Peak Advisors's ORGO Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Organogenesis Holdings (ORGO) in Q4 2022, closing a stake of 19,890 shares — an estimated $64K sold.

Ensign Peak Advisors first reported a position in ORGO in Q2 2021 and held it in 6 quarters. The position peaked at $693K in Q2 2021. 150 funds tracked by Wall St. Rank hold ORGO as of Q4 2022.

  • Ensign Peak Advisors reported no remaining Organogenesis Holdings position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 19,890 Organogenesis Holdings shares in Q4 2022, an estimated $64K.
  • Ensign Peak Advisors first reported a position in Organogenesis Holdings in Q2 2021 and held it in 6 quarters.
  • Ensign Peak Advisors's Organogenesis Holdings position peaked at $693K in Q2 2021.
  • 150 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.